73 results
Page 3 of 4
8-K
EX-99.1
9g5fpxv 6iil6gjlslzg
20 Jul 21
Regulation FD Disclosure
8:36am
8-K
EX-99.2
dgl3sa1b29iguy w4ip
20 Jul 21
Regulation FD Disclosure
8:36am
8-K
8erfswy7a5s9
20 Jul 21
Regulation FD Disclosure
8:36am
8-K
EX-99.1
tbojt1
17 Jun 21
Immunome Appoints Franklyn G. Prendergast, M.D., Ph.D. to Board of Directors
4:55pm
8-K
EX-99.1
fv6a 6oxx
20 May 21
Immunome Announces Additional $4.3 Million Award by DOD following Positive Preclinical Testing Results on COVID-19 Variants of Concern
9:07am
8-K
EX-99.1
xz0b6 a6oorv
12 May 21
Immunome Reports First Quarter 2021 Financial Results
6:05am
8-K
EX-99.1
gqhxegesqz3h nt2j8
26 Apr 21
Regulation FD Disclosure
6:07am
8-K
yvk9bmopet eyzc68t5
26 Apr 21
Regulation FD Disclosure
6:07am
8-K
EX-99.1
geedvs8
26 Apr 21
Immunome Announces $27 Million Private Placement
6:05am
8-K
d3t9v54
20 Apr 21
Departure of Directors or Certain Officers
4:48pm
8-K
EX-10.1
cz83a5 tia5z1
20 Apr 21
Departure of Directors or Certain Officers
4:48pm
DEF 14A
tgxgo
16 Apr 21
Definitive proxy
3:35pm
8-K
EX-99.1
bnc puo9l3gkc20s
29 Mar 21
Regulation FD Disclosure
6:02am
8-K
az3 jlkuq9hb
29 Mar 21
Regulation FD Disclosure
6:02am
8-K
EX-99.1
rva t6ffvm
25 Mar 21
Immunome Reports Fourth Quarter and Full Year 2020 Financial Results, Provides Corporate Update
5:30pm
10-K
EX-10.26
lrmxra vc2e4s2g1et
25 Mar 21
Annual report
5:01pm
10-K
nkuchn j8qp
25 Mar 21
Annual report
5:01pm
10-K
EX-10.27
r7jt uo9llkmi
25 Mar 21
Annual report
5:01pm
8-K
EX-99.1
7v2ll96uwc
16 Mar 21
Regulation FD Disclosure
6:00am
8-K
0mdmi5do
16 Mar 21
Regulation FD Disclosure
6:00am